chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness, Lymphadenopathy, Myalgia, Nausea, Pruritus
Clinical narrative: fatigue; itchy small bumps on stomach and back; itchy small bumps (hives) on stomach and back; fever; chills; sore muscles; sore/stiff joints; sore/stiff joints; headache; nausea; fatigue; swollen lymph nodes in shot arm; inappropriate schedule of vaccine administration; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation (Inappropriate schedule of vaccine administered). The patient had no medical history. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021 at 06:00, the patient experienced fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue and swollen lymph nodes in the arm. On 20Apr2021, the patient experienced fatigue, headache, hives, itchy small bumps on the stomach and back. The patient did not receive any treatment for the reported events. The adverse event did not result in a doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue, swollen lymph nodes in the arm, fatigue, headache, itchy small bumps on stomach and back and hives were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: fatigue; itchy small bumps on stomach and back; itchy small bumps (hives) on stomach and back; fever; chills; sore muscles; sore/stiff joints; sore/stiff joints; headache; nausea; fatigue; swollen lymph nodes in shot arm; inappropriate schedule of vaccine administration; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation (Inappropriate schedule of vaccine administered). The patient had no medical history. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04Apr2021 at 16:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. On 19Apr2021 at 06:00, the patient experienced fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue and swollen lymph nodes in the arm. On 20Apr2021, the patient experienced fatigue, headache, hives, itchy small bumps on the stomach and back. The patient did not receive any treatment for the reported events. The adverse event did not result in a doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fever, chills, sore muscles, sore joints, stiff joints, headache, nausea, fatigue, swollen lymph nodes in the arm, fatigue, headache, itchy small bumps on stomach and back and hives were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about the lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Discomfort, Muscle spasms, Myalgia, Peripheral swelling
Clinical narrative: swollen left leg; muscle soreness; cramping leg and knee; medium discomfort; extreme discomfort with left knee, treated as arthritis; This is spontaneous report from a contactable consumer (patient). This case is for first dose. An elderly non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: EWO175), dose 1 via an unspecified route of administration, administered in Arm Left on 30Apr2021 10:30 as a single dose for covid-19 immunisation. Medical history included hypertension, age related blood pressure, asthma, drug hypersensitivity. The patient's concomitant medications were not reported. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that, after administration of first dose the patient had swollen left leg, muscle soreness, cramping leg and knee, medium discomfort, then extreme discomfort with left knee, treated as arthritis. The patient did not receive any treatment. The outcome of the events was not recovered. Device Date was 03May2021  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Nausea, Pain
Clinical narrative: severe aching all over my body; Severe fatigue; severe headache; nausea; vomiting; fever up to 102 degrees F; This is a spontaneous report from a contactable nurse. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8727) via an unspecified route of administration in the left arm on 14Apr2021 at 09:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, hypertension, restless leg syndrome and allergic to sulfa drugs. Concomitant medications included insulin (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO), dulaglutide (TRULICITY), dapagliflozin propanediol monohydrate (FARXIGA) and losartan potassium (LOSA), all from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208) via an unspecified route of administration in the right arm on 24Mar2021 at 09:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient previously took liraglutide (VICTOZA) and amoxicillin, clavulanate potassium (AUGMENTIN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Apr2021 at 15:00, the patient experienced severe aching all over the body, severe fatigue, severe headache, nausea, vomiting and fever up to 102 degrees F. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received zofran, ibuprofen, bedrest, cold shower and fluids as treatment for the reported events.  The patient underwent lab tests which included body temperature and tested with a temperature up to 102 degrees F. The clinical outcome of the events severe aching all over body, severe fatigue, severe headache, nausea, vomiting and fever was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: severe aching all over my body; Severe fatigue; severe headache; nausea; vomiting; fever up to 102 degrees F; This is a spontaneous report from a contactable nurse. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8727) via an unspecified route of administration in the left arm on 14Apr2021 at 09:45(at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, hypertension, restless leg syndrome and allergic to sulfa drugs. Concomitant medications included insulin (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO), dulaglutide (TRULICITY), dapagliflozin propanediol monohydrate (FARXIGA) and losartan potassium (LOSA), all from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208) via an unspecified route of administration in the right arm on 24Mar2021 at 09:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient previously took liraglutide (VICTOZA) and amoxicillin, clavulanate potassium (AUGMENTIN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Apr2021 at 15:00, the patient experienced severe aching all over the body, severe fatigue, severe headache, nausea, vomiting and fever up to 102 degrees F. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received zofran, ibuprofen, bedrest, cold shower and fluids as treatment for the reported events.  The patient underwent lab tests which included body temperature and tested with a temperature up to 102 degrees F. The clinical outcome of the events severe aching all over body, severe fatigue, severe headache, nausea, vomiting and fever was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Unexpected menstrual spotting 48 hours after second dose; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FL9266) via an unspecified route of administration in the left arm on 04May2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and allergy to sulfa drugs. Concomitant medications included unspecified oral birth control (MANUFACTURER UNKNOWN) and levothyroxine sodium (SYNTHROID); both started on an unknown date for unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: eR8729) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 06May2021, the patient experienced unexpected menstrual spotting 48 hours after the second dose. The clinical outcome of the event unexpected menstrual spotting was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Headache; Body aches; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm left on 05May2021 at 13:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient had no known allergies. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN) and levocetirizine (MANUFACTURER UNKNOWN)  all for unspecified indications from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Apr2021 at 13:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 21:30 the patient experienced headache, body aches and nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events headache, body aches and nausea was resolving at the time of report.   No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Severe chills; Joint pain; Severe fever; Very severe nausea; Vomiting; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the arm left on 04May2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included dexamethasone, neomycin sulfate, polymyxin b sulfate (MAXITROL) eyedrop from an unknown date for unspecified indication. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0151) via an unspecified route of administration in the left arm on 06Apr2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID -19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 09:00, the patient experienced injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No therapeutic measures were taken as a result of the reported events. The clinical outcomes of injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell were recovering.    No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Injection site pain; Tiredness; Headache; Muscle pain; Severe chills; Joint pain; Severe fever; Very severe nausea; Vomiting; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the arm left on 04May2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included dexamethasone, neomycin sulfate, polymyxin b sulfate (MAXITROL) eyedrop from an unknown date for unspecified indication. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0151) via an unspecified route of administration in the left arm on 06Apr2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID -19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 09:00, the patient experienced injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No therapeutic measures were taken as a result of the reported events. The clinical outcomes of injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell were recovering.    No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: Fatigued; Massive headache; Nausea; Severe chills; Fever of 101F; Felt very achy; This is a spontaneous report from a contactable pharmacist, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 05May2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 14Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05May2021 around 23:00, the patient felt really achy. On 06May2021, around midnight, the patient experienced severe chills and fever of 101F. On 06May2021, by around 03:00 to 04:00, the chills had reduced and fever was gone but the patient felt very achy and had a massive headache with nausea. By 08:00, the chills were essentially gone but the patient felt very achy and fatigued.  The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with zofran, tylenol and ibuprofen. The clinical outcome of the events fever of 101F and severe chills were resolved on 06May2021 at 04:00 and 08:00 respectively, while the outcome of the events headache, nausea and fatigued were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fatigued; Massive headache; Nausea; Severe chills; Fever of 101F; Felt very achy; This is a spontaneous report from a contactable pharmacist, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 05May2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 14Apr2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05May2021 around 23:00, the patient felt really achy. On 06May2021, around midnight, the patient experienced severe chills and fever of 101F. On 06May2021, by around 03:00 to 04:00, the chills had reduced and fever was gone but the patient felt very achy and had a massive headache with nausea. By 08:00, the chills were essentially gone but the patient felt very achy and fatigued.  The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with zofran, tylenol and ibuprofen. The clinical outcome of the events fever of 101F and severe chills were resolved on 06May2021 at 04:00 and 08:00 respectively, while the outcome of the events headache, nausea and fatigued were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability, Paraesthesia, Rash erythematous
Clinical narrative: Red rash on inner arms, top of legs and stomach; Tingling; Very irritating; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CSHDER8731), via an unspecified route of administration in the left arm on 28Apr2021 (at the age of 45-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included acetylsalicylic acid; caffeine; salicylamide (EXCEDRIN), paracetamol; pseudoephedrine hydrochloride (TYLENOL SINUS), loratadine (CLARITIN) and gummy vitamin (MANUFACTURER UNKNOWN) all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CSHDER8731), via an unspecified route of administration in the right arm on an unknown date at 11:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Apr2021 at 12:00 (day of second shot), the patient experienced a red rash on inner arms, top of legs and stomach, tingling and very irritating when used the tanning bed. No therapeutic measures were taken for the events. The clinical outcome of the events red rash on inner arms top of legs and stomach, tingling and very irritating were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenopia, Chills, Fatigue, Malaise, Nausea
Clinical narrative: Feverish; Chills; Extremely exhausted; definitely had some tiredness in my eyes; Started to feel nausea before I went to sleep; woke up in the middle of the night feeling very sick/The following day I was pretty sick; Ended up throwing up a good bit; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and COVID-19 on unknown date. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021 at 16:00, the day the patient got vaccine, the patient felt mostly fine, definitely had some tiredness in eyes. The patient started to feel nausea before he went to sleep, woke up in the middle of the night feeling very sick. The patient ended up throwing up a good bit. On 21Apr2021, the following day, the patient was pretty sick, feverish, chills and extremely exhausted. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events tiredness in eyes, nausea, feeling sick, throwing up a good bit, feverish, chills and extremely exhausted was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Feverish; Chills; Extremely exhausted; definitely had some tiredness in my eyes; Started to feel nausea before I went to sleep; woke up in the middle of the night feeling very sick/The following day I was pretty sick; Ended up throwing up a good bit; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and COVID-19 on unknown date. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021 at 16:00, the day the patient got vaccine, the patient felt mostly fine, definitely had some tiredness in eyes. The patient started to feel nausea before he went to sleep, woke up in the middle of the night feeling very sick. The patient ended up throwing up a good bit. On 21Apr2021, the following day, the patient was pretty sick, feverish, chills and extremely exhausted. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events tiredness in eyes, nausea, feeling sick, throwing up a good bit, feverish, chills and extremely exhausted was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Pain, Pruritus, Sunburn
Clinical narrative: Extreme sunburn, Ive been sunburnt in the past but this seemed to have made it way worse.; After being burnt 6 days ago its still bright red; Painful; Itchy; Blistery; This is a spontaneous report from a contactable consumer, the patient. A 40-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 28Apr2021 at 18:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient medical history included sunburn. The patient had no allergies to medications, food or other products. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm right arm on 07Apr2021 at 18:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 the patient experienced extreme sunburn, erythema, pain, itchy and blister. (It was reported that the patient had extreme sunburn, she had been sunburnt in the past but this seemed to have made it way worse. After being burnt 6 days before it was still bright red, painful, itchy and blistery). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events extreme sunburn, erythema, pain, itchy and blistery was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Feeling abnormal, Headache
Clinical narrative: Migraine; Vomiting; Diarrhea; Chills; Headache; Brain fog; Fever; Joints ached.; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179), via an unspecified route of administration in the left arm on 05May2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis, migraine, aneurysms, anxiety/depression and colitis. Concomitant medications included adalimumab (HUMIRA), botulinum toxin type a (BOTOX), rizatriptan (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and lamotrigine (LAMOTRIGIN) all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162), via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 12:30, about 3 hours after the vaccine the patient experienced brain fog. On 05May2021 at 15:30, about five hours after the vaccine, the patient experienced headache. On 05May2021 at 21:30, the patient experienced chills (12 hours after shot). On 05May2021, the patient experienced back and forth fever all night and also reported that all of her joints ached during the night. The following day on 06May2021, the patient experienced migraine, vomiting, diarrhea. The patient reported that she still had achy joints and chills/fever. The patient reported that 48 hours post shot she still had a migraine but the other effects were gone. The events did not result in a doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events brain fog, headache, chills, fever, joints ached, migraine, vomiting and diarrhea. The clinical outcome of the events brain fog, vomiting, headache, chills, fever, joint ache and diarrhea were resolved on 07May2021. The clinical outcome of the event migraine was recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia, Vomiting
Clinical narrative: Migraine; Vomiting; Diarrhea; Chills; Headache; Brain fog; Fever; Joints ached.; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179), via an unspecified route of administration in the left arm on 05May2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included ankylosing spondylitis, migraine, aneurysms, anxiety/depression and colitis. Concomitant medications included adalimumab (HUMIRA), botulinum toxin type a (BOTOX), rizatriptan (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and lamotrigine (LAMOTRIGIN) all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162), via an unspecified route of administration in the left arm on 14Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 12:30, about 3 hours after the vaccine the patient experienced brain fog. On 05May2021 at 15:30, about five hours after the vaccine, the patient experienced headache. On 05May2021 at 21:30, the patient experienced chills (12 hours after shot). On 05May2021, the patient experienced back and forth fever all night and also reported that all of her joints ached during the night. The following day on 06May2021, the patient experienced migraine, vomiting, diarrhea. The patient reported that she still had achy joints and chills/fever. The patient reported that 48 hours post shot she still had a migraine but the other effects were gone. The events did not result in a doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events brain fog, headache, chills, fever, joints ached, migraine, vomiting and diarrhea. The clinical outcome of the events brain fog, vomiting, headache, chills, fever, joint ache and diarrhea were resolved on 07May2021. The clinical outcome of the event migraine was recovering at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Transient global amnesia
Clinical narrative: TRANSIENT GLOBAL AMNESIA; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm in Apr2021 at 00:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since the vaccination the patient has been tested for COVID. On 04May2021 at 00:00, the patient experienced transient global amnesia.  On 04May2021, the patient underwent a nasal swab test and the result was negative. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of transient global amnesia and included treatment with aspirin (MANUFACTURER UNKNOWN). The clinical outcome of the event transient global amnesia was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Dysphagia, Furuncle, Paraesthesia oral
Clinical narrative: Tingling lips and fingers; Red, zit like bumps on arms; Difficulty swallowing; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old patient with unspecified gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 07May2021 at 13:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included gout. The patient had no known allergies. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and omega 3 (MANUFACTURER UNKNOWN) all from unknown dates and unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021 at 13:15, the patient experienced tingling lips and fingers, red zit like bumps on arms and difficulty swallowing. Therapeutic measures were taken as a result of these events which included treatment with benadryl syrup (MANUFACTURER UNKNOWN). The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events tingling lips and fingers, red zit like bumps on arms and difficulty swallowing was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Lymphadenopathy, Pain
Clinical narrative: Dizziness; Fatigue; Body aches; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER0169) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any concomitant medications. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 07:00, the patient experienced dizziness, fatigue, body aches and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events dizziness, fatigue, body aches and swollen lymph nodes were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Polymenorrhoea
Clinical narrative: Menstrual cycles every other week; This is a spontaneous report from a contactable nurse, the patient.   A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 15:00 (at the age of 50-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to food, medications, or other products. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 07:00, since the vaccination, the patient started having menstrual cycles every other week which lasted for 5-6 days. However, prior to the vaccination the patient had a regular cycle of every 28 days. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event menstrual cycles every other week was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Dysmenorrhoea, Dyspnoea
Clinical narrative: shortness of breath; injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; diarrhea; arm pain; swelling of my feet; painful it was hard to walk; my period came two weeks early; was more painful than normal; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the left arm on 06Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, blood pressure high, mitral valve prolapse and allergy to bee stings and chicory root. The patient previously took penicillin (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 10:15, the patient experienced shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, and swelling of feet so uncomfortable and painful and was hard to walk. Also, her period came two weeks early and was more painful than normal which was very unusual. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, swelling of feet, painful feet, early period and painful period were recovered with sequelae on unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Menstruation irregular, Myalgia, Pain in extremity
Clinical narrative: shortness of breath; injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; diarrhea; arm pain; swelling of my feet; painful it was hard to walk; my period came two weeks early; was more painful than normal; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the left arm on 06Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, blood pressure high, mitral valve prolapse and allergy to bee stings and chicory root. The patient previously took penicillin (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 10:15, the patient experienced shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, and swelling of feet so uncomfortable and painful and was hard to walk. Also, her period came two weeks early and was more painful than normal which was very unusual. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, swelling of feet, painful feet, early period and painful period were recovered with sequelae on unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: shortness of breath; injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; diarrhea; arm pain; swelling of my feet; painful it was hard to walk; my period came two weeks early; was more painful than normal; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the left arm on 06Apr2021 at 09:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, blood pressure high, mitral valve prolapse and allergy to bee stings and chicory root. The patient previously took penicillin (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 10:15, the patient experienced shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, and swelling of feet so uncomfortable and painful and was hard to walk. Also, her period came two weeks early and was more painful than normal which was very unusual. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events shortness of breath, injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, diarrhea, arm pain, swelling of feet, painful feet, early period and painful period were recovered with sequelae on unknown date in May2021.   No follow-up attempts are needed. No further information is expected.